Authorization of the Shares and Warrants. The Company has authorized, or before the Closing, as defined in paragraph 2.1 hereof, will have authorized, the issuance and sale of: (a) up to 5,000,000 shares of its Series E Preferred Stock (the "Shares") and (b) warrants (the "Warrants") to purchase up to 2,500,000 shares of the Company's Series E Preferred Stock with an exercise price of $2.00 per share (the "Warrant Shares"), at a purchase price of $2.00 per Share and Warrant Share (a "Unit"). As used herein, a Unit is comprised of one share of Series E Preferred Stock and one Warrant, in substantially the form set forth in EXHIBIT B hereto, to purchase one-half of a share of Series E Preferred Stock.
Appears in 3 contracts
Sources: License Agreement (Cv Therapeutics Inc), License Agreement (Cv Therapeutics Inc), License Agreement (Cv Therapeutics Inc)